InsidersTradesSigma
Dawnrays Pharmaceutical (Holdings) Ltd. Stock: price and management transactions · Hong Kong · HKEX
Follow the Dawnrays Pharmaceutical (Holdings) Ltd. stock price and the full insider trade history of the company, a listed issuer based in Hong Kong. Shares are listed on HK HK, under the supervision of HKEX. Operating in the Health Care sector, Dawnrays Pharmaceutical (Holdings) Ltd. has recorded 17 public disclosures. Market capitalisation: €1.5bn. The latest transaction was reported on 29 June 2026 (Purchase). Among the most active insiders: Hung Yung Lai. All data is free.
17
Insider Decl.
0
Thresholds
€86,024
16 ops.
Buy Volume
·
0 ops.
Sell Volume
29Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 748 of 26,134 companies
82.3
score / 100
Value93
Quality72
FCF yld16%
Earn yld14%
EV/EBITDA4.2x
ROE6.3%
Gross mgn50%
Net mgn17%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 29 June 2026
Declarations17 total
72,000 shares@ €0.1123ShareXHKGHKEX:DA20260626E00360
Ideal exit: 22 Mar 2027 (T+270)
72,000 shares@ €0.1123ShareXHKGHKEX:DA20260626E00345
Ideal exit: 22 Mar 2027 (T+270)
36,000 shares@ €0.12370.0027% mcap12.7% of flowShareXHKGHKEX:DA20260514E00650
Ideal exit: 8 Feb 2027 (T+270)
36,000 shares@ €0.12370.0027% mcap12.7% of flowShareXHKGHKEX:DA20260514E00647
Ideal exit: 8 Feb 2027 (T+270)
52,000 shares@ €0.12510.0039% mcap18.6% of flowShareXHKGHKEX:DA20260508E00513
Ideal exit: 1 Feb 2027 (T+270)
52,000 shares@ €0.12510.0039% mcap18.6% of flowShareXHKGHKEX:DA20260508E00494
Ideal exit: 1 Feb 2027 (T+270)
8,000 shares@ €0.12180.0006% mcap2.8% of flowShareXHKGHKEX:DA20260423E00021
Ideal exit: 16 Jan 2027 (T+270)
8,000 shares@ €0.12180.0006% mcap2.8% of flowShareXHKGHKEX:DA20260423E00020
Ideal exit: 16 Jan 2027 (T+270)
44,000 shares@ €0.12110.0003% mcap15.3% of flowShareXHKGHKEX:DA20260416E00055
Ideal exit: 10 Jan 2027 (T+270)
44,000 shares@ €0.12110.0003% mcap15.3% of flowShareXHKGHKEX:DA20260416E00051
Ideal exit: 10 Jan 2027 (T+270)
20,000 shares@ €0.12260.0001% mcap7.0% of flowShareXHKGHKEX:DA20260415E00002
Ideal exit: 8 Jan 2027 (T+270)
20,000 shares@ €0.12260.0001% mcap7.0% of flowShareXHKGHKEX:DA20260415E00001
Ideal exit: 8 Jan 2027 (T+270)
40,000 shares@ €0.12550.0003% mcap14.4% of flowShareXHKGHKEX:DA20260403E00005
Ideal exit: 27 Dec 2026 (T+270)
40,000 shares@ €0.12550.0003% mcap14.4% of flowShareXHKGHKEX:DA20260403E00004
Ideal exit: 27 Dec 2026 (T+270)
84,000 shares@ €0.12140.0006% mcap29.2% of flowShareXHKGHKEX:DA20260331E00419
Ideal exit: 25 Dec 2026 (T+270)
84,000 shares@ €0.12140.0006% mcap29.2% of flowShareXHKGHKEX:DA20260331E00415
Ideal exit: 25 Dec 2026 (T+270)
17 of 17 declarations
About Dawnrays Pharmaceutical (Holdings) Ltd.
Dawnrays Pharmaceutical (Holdings) Ltd. is a company focused on the development and manufacturing of pharmaceutical products. It is listed on the Hong Kong Stock Exchange (XHKG).